KSCYX | VEXRX | KSCYX / VEXRX | |
Total Expense Ratio | 1.44 | 0.33 | 436% |
Annual Report Gross Expense Ratio | 1.64 | 0.33 | 497% |
Fund Existence | 20 years | 24 years | - |
Gain YTD | 2.885 | 0.796 | 363% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 50000 | 2,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 526M | 19.4B | 3% |
Annual Yield % from dividends | 1.79 | 0.52 | 342% |
Returns for 1 year | 36.95 | 1.29 | 2,868% |
Returns for 3 years | 71.37 | 20.96 | 341% |
Returns for 5 years | 255.35 | 13.21 | 1,932% |
Returns for 10 years | 387.14 | 18.20 | 2,128% |
1 Day | |||
---|---|---|---|
CRYPTO / NAME | Price $ | Chg $ | Chg % |
COMP.X | 41.397205 | 0.276890 | +0.67% |
Compound cryptocurrency | |||
EMGF | 52.70 | 0.34 | +0.65% |
iShares Em Mkts Eq Fac ETF | |||
PJP | 81.38 | 0.09 | +0.11% |
Invesco Pharmaceuticals ETF | |||
GSJY | 41.76 | 0.01 | +0.03% |
Goldman Sachs ActiveBeta® Japan Eq ETF | |||
DMAT | 16.88 | -0.09 | -0.53% |
Global X Disruptive Materials ETF |